ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 130 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,166,076 | +10.8% | 170,230 | +67.7% | 0.01% | +16.7% |
| Q2 2023 | $1,052,545 | -42.5% | 101,499 | -55.1% | 0.01% | -52.0% |
| Q1 2023 | $1,829,974 | -80.7% | 226,202 | -62.5% | 0.02% | -80.3% |
| Q4 2022 | $9,489,674 | -13.5% | 602,519 | -13.6% | 0.13% | -17.0% |
| Q3 2022 | $10,971,000 | +26.4% | 697,007 | +12.1% | 0.15% | +14.2% |
| Q2 2022 | $8,677,000 | -19.0% | 621,557 | +4.5% | 0.13% | -23.4% |
| Q3 2021 | $10,706,000 | – | 594,768 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |